The Lilabean Foundation’s support will accelerate pace of translational research, discovery of new treatments for children and young adults with brain tumors.

Study makes the case for Leigh syndrome to be considered a potential diagnosis for infants and children with early developmental delays.

In two separate studies, researchers present data specific to early diagnosis and treatment of candidiasis, a life-threatening fungal infection.

CHOP researchers have found that chemo-resistant mesenchymal cells in neuroblastoma might be vulnerable to immunotherapy.

A new study in Nature has documented the longest persistence of CAR T cell therapy to date.

The method could eventually lead to more personalized medicine approaches as well as properly diagnose patients with multiple disorders.

CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.

Method measures motor imitation skills, which have been challenging to measure consistently and precisely.

As part of a longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s Hospital of Philadelphia (CHOP)will exhibit leading medical breakthroughs in the EHS booth at the annual Arab Health Exhibition and Congress, which is taking place at the Dubai International Convention and Exhibition Centre this week.

New test analyzes mitochondrial DNA to find and quantify certain variations and deletions, providing a useful diagnostic tool that helps guide treatment.